Abstract

Randomized, open-label, multicenter, phase III study of eribulin versus dacarbazine in patients (pts) with leiomyosarcoma (LMS) and adipocytic sarcoma (ADI).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Randomized, open-label, multicenter, phase III study of eribulin versus dacarbazine in patients (pts) with leiomyosarcoma (LMS) and adipocytic sarcoma (ADI).
Patrick Schöffski ... Peter Hohenberger
Journal of Clinical Oncology | VOL. 33
Patrick Schöffski, et. al.Patrick Schöffski ... Peter Hohenberger
20 Jun 2015
3441 Randomized, open-label, multicenter, phase 3 study of eribulin versus dacarbazine in patients with leiomyosarcoma and adipocytic sarcoma: Health-related quality of life results
H Gelderblom ... P Schoffski
European Journal of Cancer | VOL. 51
H Gelderblom, et. al.H Gelderblom ... P Schoffski
01 Sep 2015
510P Safety and efficacy of eribulin mesylate in patients with advanced soft tissue sarcoma in daily practice
C Inagaki ... K Tamura
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 27
C Inagaki, et. al.C Inagaki ... K Tamura
01 Dec 2016
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial
Martee L Hensley ... George D Demetri
Gynecologic oncology | VOL. 146
Martee L Hensley, et. al.Martee L Hensley ... George D Demetri
24 Jun 2017

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
Jordan R Hansford ... Eric Bouffet
Journal of Clinical Oncology | VOL. -
Jordan R Hansford, et. al.Jordan R Hansford ... Eric Bouffet
07 Aug 2024
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials.
Rik J Verheijden ... Karijn P M Suijkerbuijk
Journal of Clinical Oncology | VOL. -
Rik J Verheijden, et. al.Rik J Verheijden ... Karijn P M Suijkerbuijk
07 Aug 2024
Structural Racism and Treatment Delay Among Black and White Patients With Breast Cancer.
Katherine E Reeder-Hayes ... Stephanie B Wheeler
Journal of Clinical Oncology | VOL. -
Katherine E Reeder-Hayes, et. al.Katherine E Reeder-Hayes ... Stephanie B Wheeler
06 Aug 2024
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial.
Akihiro Ohba ... Takuji Okusaka
Journal of Clinical Oncology | VOL. -
Akihiro Ohba, et. al.Akihiro Ohba ... Takuji Okusaka
05 Aug 2024
View more papers